Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2023 Filed Apr 4, 2023 20:29 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
GrantStock Option · Derivative | 51,959 | $74.31 Strike: $74.31 | $3,861,073.29 |
DisclosureSEC source: 0001127602-23-012229 · form4.xml · derivative · entry 5 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,959 Underlying: Common Stock · 51,959 shares Expires 2033-04-01 F3 · security: Option becomes exercisable in four equal installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:30 UTC |
Joyner J. DavidEVP&President-PharmacyServices
|
GrantStock Option · Derivative | 51,959 | $74.31 Strike: $74.31 | $3,861,073.29 |
DisclosureSEC source: 0001127602-23-012234 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,959 Underlying: Common Stock · 51,959 shares Expires 2033-04-01 F1 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:31 UTC |
Khichi Samrat S.EVP, CPO and General Counsel
|
GrantStock Option · Derivative | 66,805 | $74.31 Strike: $74.31 | $4,964,279.55 |
DisclosureSEC source: 0001127602-23-012237 · form4.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,805 Underlying: Common Stock · 66,805 shares Expires 2033-04-01 F1 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:32 UTC |
Lynch Karen SDirector · President and CEO
|
GrantStock Option · Derivative | 244,952 | $74.31 Strike: $74.31 | $18,202,383.12 |
DisclosureSEC source: 0001127602-23-012242 · form4.xml · derivative · entry 10 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,952 Underlying: Common Stock · 244,952 shares Expires 2033-04-01 F9 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:32 UTC |
Lynch Karen SDirector · President and CEO
|
Tax withholdingCommon Stock | 93,677 | $74.31 | $6,961,137.87 |
DisclosureSEC source: 0001127602-23-012242 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,933 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a performance stock unit award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:34 UTC |
Mandadi TilakEVP, Chief Technology Officer
|
GrantStock Option · Derivative | 96,496 | $74.31 Strike: $74.31 | $7,170,617.76 |
DisclosureSEC source: 0001127602-23-012248 · form4.xml · derivative · entry 2 Mandadi Tilak · CIK 0001872827 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,496 Underlying: Common Stock · 96,496 shares Expires 2033-04-01 F2 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:35 UTC |
PELUSO MICHELLE AEVP and Co-President of Retail
|
GrantStock Option · Derivative | 89,073 | $74.31 Strike: $74.31 | $6,619,014.63 |
DisclosureSEC source: 0001127602-23-012251 · form4.xml · derivative · entry 5 PELUSO MICHELLE A · CIK 0001271739 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,073 Underlying: Common Stock · 89,073 shares Expires 2033-04-01 F4 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:35 UTC |
PELUSO MICHELLE AEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 98,299 | $74.31 | $7,304,598.69 |
DisclosureSEC source: 0001127602-23-012251 · form4.xml · nonDerivative · entry 1 PELUSO MICHELLE A · CIK 0001271739 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,383 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a performance stock unit award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:36 UTC |
Shah Prem SEVP and Co-President of Retail
|
GrantStock Option · Derivative | 89,073 | $74.31 Strike: $74.31 | $6,619,014.63 |
DisclosureSEC source: 0001127602-23-012254 · form4.xml · derivative · entry 14 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,073 Underlying: Common Stock · 89,073 shares Expires 2033-04-01 F12 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:36 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 3,221 | $74.31 | $239,352.51 |
DisclosureSEC source: 0001127602-23-012254 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,364.3199 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:07 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 120 | $83.54 | $10,024.80 |
DisclosureSEC source: 0001127602-23-007946 · form4.xml · nonDerivative · entry 2 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,105.6327 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:08 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 179 | $83.54 | $14,953.66 |
DisclosureSEC source: 0001127602-23-007949 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,151.2554 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:11 UTC |
Joyner J. DavidEVP&President-PharmacyServices
|
GrantCommon Stock (Restricted) | 23,940 | $83.54 | $1,999,947.60 |
DisclosureSEC source: 0001127602-23-007953 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,940 F1 · kind: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 2/28/2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:13 UTC |
Khichi Samrat S.EVP, CPO and General Counsel
|
GrantCommon Stock (Restricted) | 47,881 | $83.54 | $3,999,978.74 |
DisclosureSEC source: 0001127602-23-007957 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,881 F1 · kind: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 2/28/2024. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:07 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 318 | $85.77 | $27,274.86 |
DisclosureSEC source: 0001127602-23-007946 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,871.6327 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:10 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
Tax withholdingCommon Stock | 4,046 | $85.77 | $347,025.42 |
DisclosureSEC source: 0001127602-23-007951 · form4.xml · nonDerivative · entry 1 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,386 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:14 UTC |
PELUSO MICHELLE AEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 12,304 | $85.77 | $1,055,314.08 |
DisclosureSEC source: 0001127602-23-007958 · form4.xml · nonDerivative · entry 1 PELUSO MICHELLE A · CIK 0001271739 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,682 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:15 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 226 | $85.77 | $19,384.02 |
DisclosureSEC source: 0001127602-23-007960 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,403.3199 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:30 UTC |
Lynch Karen SDirector · President and CEO
|
GrantCommon Stock | 206,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-003331 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,610 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on August 31, 2020. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 2, 2023. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:32 UTC |
PELUSO MICHELLE AEVP and Co-President of Retail
|
GrantCommon Stock | 192,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-003336 · form4.xml · nonDerivative · entry 1 PELUSO MICHELLE A · CIK 0001271739 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,465 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 26, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 2, 2023. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:16 UTC |
Moriarty Thomas MEVP & General Counsel
|
Tax withholdingCommon Stock | 292,856 | $93.19 | $27,291,250.64 |
DisclosureSEC source: 0001127602-23-000476 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,273.0221 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 36,490 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · derivative · entry 13 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,490 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 100,976 | $0.00 Strike: $78.05 | $0.00 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · derivative · entry 12 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,248 Underlying: Common Stock · 100,976 shares Expires 2024-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 36,490 | $98.24 | $3,584,868.83 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 4 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,129.0221 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 36,490 | $62.21 | $2,270,042.90 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644,619.0221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 100,976 | $98.40 | $9,936,311.04 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,129.0221 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:14 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 100,976 | $78.05 | $7,881,176.80 |
DisclosureSEC source: 0001127602-22-027664 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,105.0221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:43 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 153 | $101.65 | $15,552.45 |
DisclosureSEC source: 0001127602-22-026782 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,177.2554 F1 · shares: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 22:23 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 442 | $100.88 | $44,588.96 |
DisclosureSEC source: 0001127602-22-026643 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,896.7803 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| November 18, 2022 Filed Mar 14, 2025 21:02 UTC |
Finucane Anne A.Director
|
GiftCommon Stock | 800 | $97.35 | $77,880.00 |
DisclosureSEC source: 0001127602-25-009505 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 28,964 F1 · kind: Gift of shares by the reporting person to a donor-advised charitable family foundation that was not timely reported due to an administrative error. F2 · timeliness: Since June 2018, the reporting person had reported some shares as directly held when they had been moved into a trust as they were received, and also had inadvertently included an additional 1.2482 shares that had been delivered as cash in lieu of fractional shares in January 2022. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:49 UTC |
LUDWIG EDWARD JDirector
|
GrantShare Credits · Derivative | 1,323.3435 | $94.93 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-22-026164 · form4.xml · derivative · entry 3 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681.4226 Underlying: Common Stock · 1,323.3435 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:49 UTC |
LUDWIG EDWARD JDirector
|
GrantCommon Stock | 131 | $94.93 | $12,435.83 |
DisclosureSEC source: 0001127602-22-026164 · form4.xml · nonDerivative · entry 1 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,630 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:50 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 1,323 | $94.93 | $125,592.39 |
DisclosureSEC source: 0001127602-22-026165 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,849 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:51 UTC |
Balser Jeffrey R.Director
|
GrantCommon Stock | 1,323 | $94.93 | $125,592.39 |
DisclosureSEC source: 0001127602-22-026166 · form4.xml · nonDerivative · entry 1 Balser Jeffrey R. · CIK 0001751633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,947 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:52 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,402.3491 | $94.93 Strike: $0.00 | $133,125.00 |
DisclosureSEC source: 0001127602-22-026167 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,734.1051 Underlying: Common Stock · 1,402.3491 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:53 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,323.3435 | $94.93 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-22-026168 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,211.8568 Underlying: Common Stock · 1,323.3435 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:54 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,402 | $94.93 | $133,091.86 |
DisclosureSEC source: 0001127602-22-026169 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,162 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:55 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 3,212.8937 | $94.93 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-22-026170 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,574.897 Underlying: Common Stock · 3,212.8937 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:57 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,428 | $94.93 | $135,560.04 |
DisclosureSEC source: 0001127602-22-026172 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,320.2482 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:58 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,402 | $94.93 | $133,091.86 |
DisclosureSEC source: 0001127602-22-026173 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,811 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:59 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,764.458 | $94.93 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-22-026174 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107.3441 Underlying: Common Stock · 1,764.458 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:00 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,764.458 | $94.93 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-22-026175 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,834.4566 Underlying: Common Stock · 1,764.458 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 21:33 UTC |
Balser Jeffrey R.Director
|
GrantCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022423 · form4.xml · nonDerivative · entry 1 Balser Jeffrey R. · CIK 0001751633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:47 UTC |
Shah Prem SEVP and Co-President of Retail
|
GrantCommon Stock (RSU) | 20,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022028 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,376 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:48 UTC |
Mandadi TilakEVP, Chief Technology Officer
|
GrantCommon Stock (RSU) | 99,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022030 · form4.xml · nonDerivative · entry 1 Mandadi Tilak · CIK 0001872827 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,847 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:50 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantCommon Stock (RSU) | 12,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022032 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,735 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionStock Option · Derivative | 22,541 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · derivative · entry 12 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,541 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
SaleCommon Stock | 22,541 | $104.00 | $2,344,264.00 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · nonDerivative · entry 6 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,183.3689 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionCommon Stock | 22,541 | $62.21 | $1,402,275.61 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · nonDerivative · entry 5 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,724.3689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionStock Option · Derivative | 50,501 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · derivative · entry 11 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,201 Underlying: Common Stock · 50,501 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.